Turning Point Benefit Group »

Monte Rosa Therapeutics shares owned by Turning Point Benefit Group

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Turning Point Benefit Group from 13F filings

Historical chart of Turning Point Benefit Group investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Turning Point Benefit Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Turning Point Benefit Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $105 14 7.50

More positions owned by Turning Point Benefit Group

Spdr Series Trust Etf (BIL)
Spdr Series Trust Etf (SPLG)
Northern Lts Fd Tr Iv Etf (WWJD)
Ishares Tr Etf (FLOT)
Wheaton Precious Metals Corp (WPM)
Capital Group U S Multi Sec Etf (CGMS)
Dimensional Etf Trust Etf (DFIV)
Spdr Index Shs Fds Etf (SPEM)
Timothy Plan cmn (TPSC)
Vanguard Whitehall Fds Etf (VYMI)
Rowe Price Etf Etf (TFLR)
Invesco Exch Traded Fd Tr Ii Etf (QQQM)
Ishares Gold Tr (IAUM)
Spdr Gold Tr Etf (GLD)
First Tr Exchange-traded Etf (FDL)

View all positions for Turning Point Benefit Group

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Versant Venture Management
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
Aisling Capital Management
Alphabet
Geode Capital Management
Marshall Wace
State Street Corporation
Vestal Point Capital
Northern Trust

View all funds holding Monte Rosa Therapeutics